|
MLTX MoonLake Immunotherapeutics 1821586 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-69,707,000.00 |
| Balance Sheet |
|
Current Assets
|
$396,641,000.00 |
|
Assets
|
$400,374,000.00 |
|
Current Liabilities
|
$46,114,000.00 |
|
Liabilities
|
$146,350,000.00 |
|
Equity
|
$254,024,000.00 |
|
Shares Out
|
73615396.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-66,286,000.00 |
|
Investing Cash Flow
|
$98,000.00 |
| Market Analysis |
Market Cap
|
$1,397,956,370.04 |
|
Price
|
$17.72 |
|
BVPS
|
3.45 |
|
PB
|
5.50 |
|
EPS
|
-0.98 |
|
FCF
|
$-66,286,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:20 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-25 |
-3.53 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-10 |
-0.98 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.87 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-1.10 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MLTX documents filed with the SEC.
MLTX Filings
Clear
